Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Filippou

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Seminars in Arthritis and Rheumatism|January 19, 2021
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Cesar Diaz-Torne, et al.
Seminars in Arthritis and Rheumatism|May 4, 2021
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Georgios Filippou, et al.
RMD Open|May 14, 2016
Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE studyMaria-Antonietta D'Agostino, Maarten Boers, Richard J Wakefield, et al.
Rheumatology (Oxford, England)|September 23, 2024
Diagnostic accuracy of hip joint ultrasound for detection of calcium pyrophosphate depositionCarina Soto-Fajardo, Fabián Carranza-Enríquez, Raúl Pichardo-Bahena, et al.
Clinical and Experimental Rheumatology|February 18, 2016
Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition diseaseGeorgios Filippou, Antonella Adinolfi, Marco A Cimmino, et al.
Annals of the Rheumatic Diseases|November 22, 2015
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE studyMaria-Antonietta D'Agostino, Richard J Wakefield, Hilde Berner-Hammer, et al.
Frontiers in Medicine|March 27, 2023
Which are the most frequently involved peripheral joints in calcium pyrophosphate crystal deposition at imaging? A systematic literature review and meta-analysis by the OMERACT ultrasound - CPPD subgroupAntonella Adinolfi, Silvia Sirotti, Garifallia Sakellariou, et al.
Frontiers in Medicine|May 28, 2020
Differential Diagnosis of Inflammatory Arthropathies by Musculoskeletal Ultrasonography: A Systematic Literature ReviewGarifallia Sakellariou, Carlo Alberto Scirè, Antonella Adinolfi, et al.
Arthritis Care & Research|April 19, 2022
Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working GroupSara K Tedeschi, Fabio Becce, Tristan Pascart, et al.
Rheumatology (Oxford, England)|May 22, 2023
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritisJulien Damart, Georgios Filippou, Mariano Andrès, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Seminars in Arthritis and Rheumatism|January 19, 2021
Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): A content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Cesar Diaz-Torne, et al.
Seminars in Arthritis and Rheumatism|May 4, 2021
Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working groupAmy Fuller, Ken Cai, Georgios Filippou, et al.
RMD Open|May 14, 2016
Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE studyMaria-Antonietta D'Agostino, Maarten Boers, Richard J Wakefield, et al.
Rheumatology (Oxford, England)|September 23, 2024
Diagnostic accuracy of hip joint ultrasound for detection of calcium pyrophosphate depositionCarina Soto-Fajardo, Fabián Carranza-Enríquez, Raúl Pichardo-Bahena, et al.
Clinical and Experimental Rheumatology|February 18, 2016
Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition diseaseGeorgios Filippou, Antonella Adinolfi, Marco A Cimmino, et al.
Annals of the Rheumatic Diseases|November 22, 2015
Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE studyMaria-Antonietta D'Agostino, Richard J Wakefield, Hilde Berner-Hammer, et al.
Frontiers in Medicine|March 27, 2023
Which are the most frequently involved peripheral joints in calcium pyrophosphate crystal deposition at imaging? A systematic literature review and meta-analysis by the OMERACT ultrasound - CPPD subgroupAntonella Adinolfi, Silvia Sirotti, Garifallia Sakellariou, et al.
Frontiers in Medicine|May 28, 2020
Differential Diagnosis of Inflammatory Arthropathies by Musculoskeletal Ultrasonography: A Systematic Literature ReviewGarifallia Sakellariou, Carlo Alberto Scirè, Antonella Adinolfi, et al.
Arthritis Care & Research|April 19, 2022
Imaging Features of Calcium Pyrophosphate Deposition Disease: Consensus Definitions From an International Multidisciplinary Working GroupSara K Tedeschi, Fabio Becce, Tristan Pascart, et al.
Rheumatology (Oxford, England)|May 22, 2023
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritisJulien Damart, Georgios Filippou, Mariano Andrès, et al.
Pageof 12